Current CMC challenges in oligonucleotide API development: from IND to NDA.
Saved in:
| Title: | Current CMC challenges in oligonucleotide API development: from IND to NDA. |
|---|---|
| Authors: | Chen D; Chemical Pharmaceutical Research Center, Changchun GeneScience Pharmaceutical Co., Ltd, Shanghai, 200120, P.R. China. chendaoqian0203@gmail.com., Zhang X; Chemical Pharmaceutical Research Center, Changchun GeneScience Pharmaceutical Co., Ltd, Shanghai, 200120, P.R. China. zhangxiaobing@genscigroup.com., Xu S; Chemical Pharmaceutical Research Center, Changchun GeneScience Pharmaceutical Co., Ltd, Shanghai, 200120, P.R. China., Liu D; Chemical Pharmaceutical Research Center, Changchun GeneScience Pharmaceutical Co., Ltd, Shanghai, 200120, P.R. China. |
| Source: | Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents [Med Chem Res] 2026 Apr; Vol. 35 (4), pp. 711-725. Date of Electronic Publication: 2026 Apr 25. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9211347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8120 (Electronic) Linking ISSN: 10542523 NLM ISO Abbreviation: Med Chem Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1554-8120 |
|---|---|
| DOI: | 10.1007/s00044-026-03569-8 |
